Posts Tagged 'mdl'

Consolidation Sought in State and Local Opioid Cases

consolidation sought in state and local opioid casesWe’ve made mention of terms like consolidation and MDL here on the blog a few times. They’re important terms to know, as they can have drastic impacts on the outcomes of very important pieces of litigation. Today’s post is no different. In fact, the use of consolidation in today’s post may set the stage for a large portion of the remainder of the nation’s response to the opioid epidemic.

As ...

continue reading...

Trouble for Diabetes Drug Makers?

invokana and farxiga mdls to move forwardKnown as SGLT2 inhibitors for short, sodium glucose co-transporter 2 inhibitors are a class of drugs intended for certain individuals with Type II diabetes. The drugs prevent glucose from being absorbed in the kidneys and reduce glucose in the blood by causing it to be expelled in the urine.

Unfortunately, this relatively new class of drugs has already allegedly caused enough ...

continue reading...

Lipitor Claims Filed in St. Louis on Behalf of 23 Women Represented by Lopez McHugh, LLP

ST. LOUIS (December 2015) – Lipitor suits have been filed in St. Louis on behalf of 23 women diagnosed with diabetes after taking the popular statin drug. The Lipitor lawsuit (Cause No. 1522-CC00478-01) was filed in the 22nd Circuit Court of Missouri in St. Louis and includes allegations that numerous women were diagnosed with type II diabetes after taking Pfizer’s blockbuster drug Lipitor.

Lipitor is prescribed for the treatment of high cholesterol levels. Millions of people in the United States ...

continue reading...

Fluoroquinolone MDL to Hold Initial Status Conference in December

An initial status conference will be held on December 8 to discuss and organize the newly centralized fluoroquinolone MDL. U.S. District Judge John Tunheim, who is overseeing the Minnesota District litigation, will likely want to appoint lawyers from both sides to leadership roles and begin the discovery process.

Fluoroquinolones (FLQs), a family of broad-spectrum antibiotics, drew attention recently when a U.S. Food and Drug Administration (FDA) panel voted to recommend that manufacturers strengthen the warning labels ...

continue reading...

U.S. Judicial Panel Approves MDL Centralizing Claims Against IVC Filter Manufacturer

judicial panel approves bard ivc filter lawsuit centralizationThe U.S. Judicial Panel on Multidistrict Litigation has ordered the transfer of all federal lawsuits filed over allegedly defective IVC filters made by medical device manufacturer C.R. Bard, Inc. to the District of Arizona following the appearance at a July 30 hearing of lead IVC filter attorney Ramon Rossi Lopez.

Lopez, founding partner of Lopez McHugh LLP, argued in favor of the transfer at the hearing in San Francisco. ...

continue reading...

Benicar MDL Tops 200 Cases

benicar mdl now over 200 casesA July 17 joint report filed before the U.S. District Court for the District of New Jersey indicates that the number of Benicar lawsuits included in multidistrict litigation (MDL) 2606 now stands at 205. This is a whopping 135 more than the 70 Benicar lawsuits reported at an MDL conference in June, and 190 more than the initial 15 federal cases centralized in March.

Benicar, pharmaceutical giant ...

continue reading...
Page 2 of 3 123